ID23250A - Komposisi paroksetin - Google Patents

Komposisi paroksetin

Info

Publication number
ID23250A
ID23250A IDW990687A ID990687A ID23250A ID 23250 A ID23250 A ID 23250A ID W990687 A IDW990687 A ID W990687A ID 990687 A ID990687 A ID 990687A ID 23250 A ID23250 A ID 23250A
Authority
ID
Indonesia
Prior art keywords
paroxsetin
composition
paroxsetin composition
Prior art date
Application number
IDW990687A
Other languages
English (en)
Inventor
Jacewicz Victor Witold
Ward Neal
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9700692.8A external-priority patent/GB9700692D0/en
Priority claimed from GBGB9714873.8A external-priority patent/GB9714873D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ID23250A publication Critical patent/ID23250A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IDW990687A 1997-01-15 1998-01-12 Komposisi paroksetin ID23250A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9700692.8A GB9700692D0 (en) 1997-01-15 1997-01-15 Novel process and compound
GBGB9714873.8A GB9714873D0 (en) 1997-07-15 1997-07-15 Novel process and compound

Publications (1)

Publication Number Publication Date
ID23250A true ID23250A (id) 2000-03-30

Family

ID=26310796

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW990687A ID23250A (id) 1997-01-15 1998-01-12 Komposisi paroksetin

Country Status (21)

Country Link
US (1) US20010049442A1 (id)
EP (1) EP0952831A1 (id)
JP (1) JP2001508460A (id)
KR (1) KR20000070151A (id)
CN (1) CN1249686A (id)
AP (1) AP9901604A0 (id)
AU (1) AU730532B2 (id)
BG (1) BG103648A (id)
BR (1) BR9806754A (id)
CA (1) CA2277480A1 (id)
EA (1) EA002034B1 (id)
HU (1) HUP0000960A3 (id)
ID (1) ID23250A (id)
IL (1) IL130856A (id)
NO (1) NO993460L (id)
NZ (1) NZ336587A (id)
OA (1) OA11077A (id)
PL (1) PL334568A1 (id)
SK (1) SK95099A3 (id)
TR (1) TR199901622T2 (id)
WO (1) WO1998031365A1 (id)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9724544D0 (en) * 1997-11-21 1998-01-21 Smithkline Beecham Plc Novel Formulation
US6168805B1 (en) * 1998-05-07 2001-01-02 Endo Pharmaceuticals, Inc. Aqueous process for manufacturing paroxetine solid dispersions
GB9810181D0 (en) * 1998-05-13 1998-07-08 Smithkline Beecham Plc Novel formulations
PT1100796E (pt) * 1998-08-07 2003-09-30 Smithkline Beecham Plc Processo para a preparacao de um cloridrato de paroxetina na forma anidra nao cristalina
GB9824298D0 (en) * 1998-11-05 1998-12-30 Smithkline Beecham Plc Novel process
ATE311883T1 (de) 1999-03-12 2005-12-15 Aesica Pharmaceuticals Ltd Stabile pharmazeutische anwendungsform für paroxetin-anhydrat
GB9914600D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel,process
ES2162560B1 (es) * 1999-06-25 2002-07-16 Rodriguez Concepcion Pena Uso de fluoxetina, paroxetina y otros isrs para la fabricacion de medicamentos con el fin de aumentar la capacidad de abstenerse de substancias o actividades que crean dependencia.
US6984632B1 (en) 1999-07-01 2006-01-10 Italfarmaco S.P.A. Complexes of paroxetine, with cyclodextrins or cyclodextrin derivatives
GB9919052D0 (en) * 1999-08-12 1999-10-13 Smithkline Beecham Plc Novel compound composition and process
GB9923439D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
GB9923446D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
US6660298B1 (en) * 2000-07-27 2003-12-09 Pentech Pharmaceuticals, Inc. Paroxetine tablets and capsules
EP1313474A2 (en) * 2000-08-28 2003-05-28 Synthon B.V. Paroxetine compositions and processes for making the same
WO2006023347A1 (en) * 2004-08-20 2006-03-02 Alpharma, Inc. Paroxetine formulations
CN104027306A (zh) * 2014-06-25 2014-09-10 万特制药(海南)有限公司 帕罗西汀口服混悬液及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2297550B (en) * 1995-02-06 1997-04-09 Smithkline Beecham Plc Paroxetine hydrochloride anhydrate substantially free of bound organic solvent
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride

Also Published As

Publication number Publication date
SK95099A3 (en) 2000-01-18
WO1998031365A1 (en) 1998-07-23
AU730532B2 (en) 2001-03-08
NO993460L (no) 1999-09-14
CN1249686A (zh) 2000-04-05
JP2001508460A (ja) 2001-06-26
BG103648A (en) 2000-04-28
EA002034B1 (ru) 2001-12-24
US20010049442A1 (en) 2001-12-06
IL130856A (en) 2001-09-13
HUP0000960A2 (hu) 2001-02-28
AU5567398A (en) 1998-08-07
CA2277480A1 (en) 1998-07-23
AP9901604A0 (en) 1999-09-30
NO993460D0 (no) 1999-07-14
HUP0000960A3 (en) 2001-04-28
OA11077A (en) 2003-03-13
EA199900655A1 (ru) 2000-02-28
PL334568A1 (en) 2000-03-13
EP0952831A1 (en) 1999-11-03
BR9806754A (pt) 2000-03-14
TR199901622T2 (xx) 1999-09-21
KR20000070151A (ko) 2000-11-25
NZ336587A (en) 2001-01-26
IL130856A0 (en) 2001-01-28

Similar Documents

Publication Publication Date Title
IS5430A (is) Ný samsetning
ID22931A (id) Komposisi-komposisi herbisidal
ID25508A (id) Komposisi dematologis
DK1298194T3 (da) Staniolholdige sammensætninger
DE69718508D1 (de) Antitraspirant zusammensetzung
ID26186A (id) Komposisi sampo
ID28694A (id) Komposisi sampo
DK0973746T3 (da) Substituerede 3-cyanoquinoliner
ID29430A (id) Komposisi herbisida
DE69832516D1 (de) Isoflavon-enthaltende zusammensetzungen
ID18359A (id) Komposisi mikrokapsul
DE69928862D1 (de) Zusammensetzung
DE69942892D1 (de) Gaserzeugende zusammensetzung
ID21009A (id) Komposisi untuk supositori
ID19589A (id) Komposisi
ID25650A (id) Komposisi-komposisi sampo
ID21906A (id) Komposisi adesif
DE59813487D1 (de) Substituierte 4-benzoyl-pyrazole
NO20002555L (no) Skjøt
BR9707835A (pt) Composiç
DE69826706D1 (de) Wäscheweichmittelzusammensetzungen
BR9709815A (pt) Composicão
ID26295A (id) Komposisi keras-ultraviolet
ID26485A (id) Komposisi paroksetina
DK0960100T3 (da) Substituerede 4-benzoyl-pyrazoler